Study details
Enrolling now
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC
H. Lee Moffitt Cancer Center and Research Institute
NCT IDNCT07476001ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Ages
18+
Sex
Male only
Locations
1 site in FL
What this study is about
This Phase 2 study is testing ADT in people with metastatic castration resistant prostate cancer.
Simplified from trial records by PatientMatch.
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Injection / IVintramuscular
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
hormone therapy, gonadorelin, Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) (Androgen Receptor Agonists)
Drug routes
injection, intramuscular
Body systems
Oncology